Free Trial

Procter & Gamble (NYSE:PG) Shares Down 0.7%

→ Log Into Marc's $5,000 System Today (From Chaikin Analytics) (Ad)

The Procter & Gamble Company (NYSE:PG - Get Free Report) was down 0.7% on Tuesday . The company traded as low as $164.56 and last traded at $164.70. Approximately 1,422,124 shares were traded during mid-day trading, a decline of 79% from the average daily volume of 6,750,905 shares. The stock had previously closed at $165.87.

Analysts Set New Price Targets

Several research analysts have recently commented on the company. Truist Financial raised Procter & Gamble from a "hold" rating to a "buy" rating and boosted their price objective for the stock from $160.00 to $175.00 in a report on Monday, March 11th. Argus raised their price objective on shares of Procter & Gamble from $180.00 to $185.00 and gave the company a "buy" rating in a research report on Thursday, April 25th. Stifel Nicolaus increased their target price on Procter & Gamble from $155.00 to $157.00 and gave the company a "hold" rating in a research note on Wednesday, January 24th. Raymond James lifted their price target on Procter & Gamble from $170.00 to $175.00 and gave the stock an "outperform" rating in a research note on Wednesday, January 24th. Finally, StockNews.com lowered Procter & Gamble from a "buy" rating to a "hold" rating in a research report on Thursday, February 29th. Seven investment analysts have rated the stock with a hold rating and twelve have assigned a buy rating to the company's stock. Based on data from MarketBeat.com, the stock currently has an average rating of "Moderate Buy" and a consensus target price of $169.76.


Get Our Latest Stock Analysis on Procter & Gamble

Procter & Gamble Stock Performance

The company has a current ratio of 0.69, a quick ratio of 0.48 and a debt-to-equity ratio of 0.49. The company has a market cap of $391.24 billion, a PE ratio of 27.01, a P/E/G ratio of 3.39 and a beta of 0.43. The business has a fifty day moving average of $160.75 and a 200-day moving average of $154.95.

Procter & Gamble (NYSE:PG - Get Free Report) last issued its quarterly earnings data on Friday, April 19th. The company reported $1.52 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $1.42 by $0.10. Procter & Gamble had a net margin of 18.00% and a return on equity of 33.91%. The business had revenue of $20.20 billion for the quarter, compared to the consensus estimate of $20.43 billion. During the same period in the previous year, the firm earned $1.37 EPS. The company's quarterly revenue was up .6% compared to the same quarter last year. Equities research analysts anticipate that The Procter & Gamble Company will post 6.55 earnings per share for the current fiscal year.

Procter & Gamble Increases Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, May 15th. Shareholders of record on Friday, April 19th will be given a dividend of $1.0065 per share. This represents a $4.03 annualized dividend and a yield of 2.43%. This is a boost from Procter & Gamble's previous quarterly dividend of $0.94. The ex-dividend date is Thursday, April 18th. Procter & Gamble's payout ratio is presently 65.85%.

Insider Transactions at Procter & Gamble

In other news, CEO R. Alexandra Keith sold 776 shares of the company's stock in a transaction dated Monday, March 4th. The shares were sold at an average price of $158.11, for a total value of $122,693.36. Following the sale, the chief executive officer now directly owns 4,859 shares of the company's stock, valued at approximately $768,256.49. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. In other Procter & Gamble news, CEO R. Alexandra Keith sold 776 shares of Procter & Gamble stock in a transaction on Monday, March 4th. The stock was sold at an average price of $158.11, for a total transaction of $122,693.36. Following the completion of the transaction, the chief executive officer now owns 4,859 shares in the company, valued at $768,256.49. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, insider Balaji Purushothaman sold 28,369 shares of the firm's stock in a transaction on Tuesday, April 23rd. The shares were sold at an average price of $161.49, for a total value of $4,581,309.81. Following the transaction, the insider now owns 11,507 shares of the company's stock, valued at $1,858,265.43. The disclosure for this sale can be found here. In the last quarter, insiders sold 140,112 shares of company stock valued at $22,841,321. Corporate insiders own 0.17% of the company's stock.

Institutional Trading of Procter & Gamble

Several institutional investors have recently added to or reduced their stakes in the business. Wellington Management Group LLP increased its holdings in Procter & Gamble by 9.4% during the third quarter. Wellington Management Group LLP now owns 35,608,913 shares of the company's stock valued at $5,193,916,000 after buying an additional 3,047,557 shares during the last quarter. Northern Trust Corp increased its stake in shares of Procter & Gamble by 2.3% in the third quarter. Northern Trust Corp now owns 29,313,150 shares of the company's stock worth $4,275,616,000 after purchasing an additional 670,862 shares in the last quarter. Norges Bank bought a new position in shares of Procter & Gamble in the fourth quarter worth about $3,956,117,000. Charles Schwab Investment Management Inc. grew its stake in Procter & Gamble by 1.3% during the fourth quarter. Charles Schwab Investment Management Inc. now owns 16,209,425 shares of the company's stock valued at $2,336,552,000 after acquiring an additional 206,165 shares in the last quarter. Finally, Royal Bank of Canada increased its holdings in Procter & Gamble by 3.2% in the 3rd quarter. Royal Bank of Canada now owns 11,170,305 shares of the company's stock valued at $1,629,299,000 after acquiring an additional 346,925 shares during the last quarter. 65.77% of the stock is currently owned by hedge funds and other institutional investors.

About Procter & Gamble

(Get Free Report)

The Procter & Gamble Company provides branded consumer packaged goods worldwide. It operates through five segments: Beauty; Grooming; Health Care; Fabric & Home Care; and Baby, Feminine & Family Care. The Beauty segment offers conditioners, shampoos, styling aids, and treatments under the Head & Shoulders, Herbal Essences, Pantene, and Rejoice brands; and antiperspirants and deodorants, personal cleansing, and skin care products under the Olay, Old Spice, Safeguard, Secret, and SK-II brands.

Featured Articles

→ Log Into Marc's $5,000 System Today (From Chaikin Analytics) (Ad)

Should you invest $1,000 in Procter & Gamble right now?

Before you consider Procter & Gamble, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Procter & Gamble wasn't on the list.

While Procter & Gamble currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Investing Strategies To Help Grow Your Retirement Income Cover

Need to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.

Get This Free Report

Featured Articles and Offers

Search Headlines: